Venmax Drugs and Pharmaceuticals Limited (BOM:531015)

BOM:531015 Revenue

In the fiscal year ending March 31, 2026, Venmax Drugs and Pharmaceuticals had annual revenue of 80.25M INR with 894.04% growth. Venmax Drugs and Pharmaceuticals had revenue of 39.44M in the quarter ending March 31, 2026, with 1,084.71% growth.

• Revenue: 80.25M
• Revenue Growth: +894.04%
• P/S Ratio: 2.91
• Revenue / Employee: 40.12M
• Employees: 2
• Market Cap: 233.74M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	80.25M	72.18M	894.04%
Mar 31, 2025	8.07M	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 21, 2026

Data Sources Report a data error